NA Vaccine Institute
Seoul, Seoul-t'ukpyolsi, South Korea
About NA Vaccine Institute
NA Vaccine Institute creates vaccine adjuvants and immune boosters with the goal of providing potentiated vaccines for global immunization. The company studies cancer therapeutic vaccines, cancer immunotherapy, infectious diseases, peptide vaccines for chronic metabolic disorders, allergy, and stroke therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Jan 2020)
- Website: navaccine.org
- Phone: 02-527-8893
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/na-vaccine-institute-2509293 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.